Sleep-disordered breathing (SDB) is characterized by repeated cessations of, or reductions in respiration during sleep. The most common form of SDB is obstructive sleep apnea, which affects from 38% to over 60% of older adults.
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1, 2 Studies of SDB in older adults largely have focused on cognition [3] [4] [5] [6] [7] [8] [9] [10] and health-related quality of life as outcomes (SF-36). [11] [12] [13] [14] [15] [16] [17] However, little is known about the association between SDB and functional decline in elders. Existing studies have provided conflicting results about these associations, [18] [19] [20] [21] but these mostly have used small samples (e.g., N <100), and likely had limited statistical power to detect effects. Thus, longitudinal studies of large cohorts are needed to determine the extent to which SDB, as measured by polysomnography (PSG) and self-reported SDB symptoms, predict multiple domains of functional decline in older adults.
Research Questions:
1.
What is the association between SDB at baseline (measured by polysomnography and selfreported symptoms) and decline in self-report measures of mobility and IADLs, and performance-based measures of function in older women?
2.
To what extent do medical comorbidities, cognitive impairment, and benzodiazepine use mediate the association between SDB and functional decline.
Data:
Visit 8 PSG Data: apnea-hypopnea index (V8RDI3P); percent sleep time spent with SaO 2 below 80% or 90% (V8PCSA80, V8PCSA90); number of desats at 3% per hr (V8DES3PH); minimum SaO 2 value during non-REM sleep (V8LSAO2N); minimum SaO 2 value during REM sleep (V8LSAO2R); central apnea index, all desats (V8CAI0P); obstructive apnea index, all desats (V8OAI0P).
Visit 8 Actigraphy Data: total sleep time (V8SMINMP); time awake after sleep onset (V8WASOMP); sleep efficiency (V8SEFNMP); sleep onset latency (V8SLATMP).
Visit 8 Form Data:
Pittsburgh Sleep Quality Index (PSQI; V8PSLPM, V8PACTSL, V8P30M, V8PWAKE, V8PBATH, V8PBREA, V8PSNOR, V8PCOLD, V8PHOT, V8PBAD, V8PPAIN, V8PLJERK, V8PHBURN, V8POTH, V8PSLMED, V8PTRBSA, V8PSQUAL, V8PENTH), Functional Status (V8FXST51, V8FXST61); sec to complete 5 chair stands and repeat (V8CHRTM, V8CHRTM2); walking speed and rapid walking speed (V8WLKSPD, V8RWKSPD); grip strength right/left/average (V8GRPRAV; V8FRPLAV; V8GRPAVG); Difficulty…climbing 10 steps (V8CLBR1), walking down 10 steps (V8STPR1), walking 2-3 blocks (V8WLKR1), preparing meals (V8CKR1), doing shopping (V8SHR1), doing heavy housework (V8HHR1); Goldberg Anxiety Scale score (V8GOLDBG); Geriatric Depression Scale score (V8GDS15); Alcohol use (V8DR30, V8DROFT, V8NDR30); Smoking (V8SMOK); Caffeine intake (V8CCOF, V8CCUP, V8CTEA, V8TCUP, V8CCOK, V8COKCAN); use of benzodiazepines (V8BENZ), antidepressants (V8ANTDEP), non-benzodiazepine sedativehypnotics (V8NBANX); Mini-Mental State Exam (V8MMSE); Trailmaking Test, Part B (V8TRTB); medical comorbidities. Visit 9 Form Data: Self-reported frequency of breathing cessations, snoring (V8STOPBR, V8SBTIMS, V8SNORE, V8OFTSNO); Functional Status (V9FXST51, V9FXST61); sec to complete 5 chair stands and repeat (V9CHRTM, V9CHRTM2); walking speed and rapid walking speed (V9WLKSPD, V9RWKSPD) ; grip strength right/left/average (V9GRPRAV; V9FRPLAV; V9GRPAVG); Difficulty…climbing 10 steps (V9CLBR1), walking down 10 steps (V9STPR1), walking 2-3 blocks (V9WLKR1), preparing meals (V9CKR1), doing shopping (V9SHR1), doing heavy housework (V9HHR1); current weight (V8WGHT); current height (V8HGHT); Mini-Mental State Exam (V9MMSE); Trailmaking Test, Part B (V9TRTB); use of benzodiazepines (V9BENZ), antidepressants (V9ANTDEP), non-benzodiazepine sedativehypnotics (V9NBANX).
Analysis Plan:
1. To determine the association between SDB at baseline and decline in self-report measures of mobility and IADLs, and in performance-based measures of function, we will conduct a series of linear and logistic regression analyses. Analyses will include data from women who completed PSG and functional measures at V8 and repeated functional measures at V9.
Each model will include a PSG-derived index or a self-reported SDB symptom (frequency of breathing cessations, snoring) as the primary predictor (analyzed both continuously and dichotomously / categorically). Outcomes will be change (from V8 to V9) in mobility and IADL impairment, and performance on performance-based functional measures. Continuous outcomes will be analyzed as continuous and dichotomous variables-the latter reflecting decline vs. no decline in absolute terms (i.e., any decline) and in sample-defined terms (e.g., highest quartile of decline).
Potential confounders will be included in models based on their association with SDB and function in prior studies (e.g., age, body mass index), and on their association with both the predictor of interest and a majority of functional outcomes at the p <.10 level (except for proposed mediators). To determine the extent to which poor self-rated sleep quality and actigraphic sleep fragmentation account for the association between SDB and outcomes, we will fit models with and without PSQI Component 1 (V8PSQUAL) or actigraphic variables as covariates.
2.
To determine the extent to which medical comorbidities, cognitive impairment, and benzodiazepine use mediate the association between SDB and functional decline, we will repeat the above analyses, adjusting for each of these potential mediators. 
